These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11156546)

  • 41. Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor beta levels in rheumatoid arthritis.
    Drynda S; Kühne C; Kekow J
    Ann Rheum Dis; 2002 Mar; 61(3):254-6. PubMed ID: 11830433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
    Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
    Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.
    Hull DN; Williams RO; Pathan E; Alzabin S; Abraham S; Taylor PC
    Clin Exp Immunol; 2015 Sep; 181(3):401-6. PubMed ID: 25766640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type II collagen autoimmunity in rheumatoid arthritis.
    Kim WU; Cho ML; Jung YO; Min SY; Park SW; Min DJ; Yoon JH; Kim HY
    Am J Med Sci; 2004 Apr; 327(4):202-11. PubMed ID: 15084916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts.
    Min DJ; Cho ML; Lee SH; Min SY; Kim WU; Min JK; Park SH; Cho CS; Kim HY
    Arthritis Rheum; 2004 Apr; 50(4):1146-55. PubMed ID: 15077296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis.
    Kim HY; Kim WU; Cho ML; Lee SK; Youn J; Kim SI; Yoo WH; Park JH; Min JK; Lee SH; Park SH; Cho CS
    Arthritis Rheum; 1999 Oct; 42(10):2085-93. PubMed ID: 10524679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different cytokine profiles in patients with chronic and acute reactive arthritis.
    Butrimiene I; Jarmalaite S; Ranceva J; Venalis A; Jasiuleviciute L; Zvirbliene A
    Rheumatology (Oxford); 2004 Oct; 43(10):1300-4. PubMed ID: 15266062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.
    Isailovic N; Ceribelli A; Cincinelli G; Vecellio M; Guidelli G; Caprioli M; Luciano N; Motta F; Selmi C; De Santis M
    Clin Exp Immunol; 2021 Aug; 205(2):142-149. PubMed ID: 33899926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis.
    Baldwin HM; Ito-Ihara T; Isaacs JD; Hilkens CM
    Ann Rheum Dis; 2010 Jun; 69(6):1200-7. PubMed ID: 19773288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Functional status of T helper cells in rheumatoid arthritis and effect of etanercept].
    Lu TT; Zhu P; Li XY; Fan CM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):495-7. PubMed ID: 18466711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired Porphyromonas gingivalis-Induced Tumor Necrosis Factor Production by Dendritic Cells Typifies Patients With Rheumatoid Arthritis.
    Santegoets KC; Wenink MH; Braga FA; Cossu M; Lamers-Karnebeek FB; van Riel PL; Sturm PD; van den Berg WB; Radstake TR
    Arthritis Rheumatol; 2016 Apr; 68(4):795-804. PubMed ID: 26606260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
    Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
    Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients.
    Gillespie J; Savic S; Wong C; Hempshall A; Inman M; Emery P; Grigg R; McDermott MF
    Arthritis Rheum; 2012 Feb; 64(2):418-22. PubMed ID: 21952924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis.
    Almanzar G; Schmalzing M; Trippen R; Höfner K; Weißbrich B; Geissinger E; Meyer T; Liese J; Tony HP; Prelog M
    J Clin Virol; 2016 Apr; 77():77-84. PubMed ID: 26921739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
    Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
    J Rheumatol; 2003 Aug; 30(8):1748-55. PubMed ID: 12913930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flow cytometric analysis of phospho-p38 mitogen-activated kinase (MAPK): p38 MAPK does not mediate the effect of adalimumab on peripheral T cell cytokine production in rheumatoid arthritis.
    Aerts NE; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
    Cytokine; 2009 Sep; 47(3):178-84. PubMed ID: 19616965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.